Mammographic casting-type calcification associated with small screen-detected invasive breast cancers: Is this a reliable prognostic indicator?

Clinical Radiology

Volumn 59, Issue 2, 2004, Pages 165-170

  Peacock, C ^a   Given Wilson, Rosalind M ^a   Duffy, S W ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Breast carcinoma; Ductal carcinoma in situ; Mammographic screening; Microcalcification

Indexed keywords

ADULT; ARTICLE; BREAST CALCIFICATION; BREAST CANCER; CANCER GRADING; CANCER INVASION; CANCER MORTALITY; CANCER RECURRENCE; CANCER RISK; CANCER SCREENING; CLINICAL ARTICLE; CONFIDENCE INTERVAL; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; FEMALE; FISHER EXACT TEST; FOLLOW UP; HIGH RISK PATIENT; HISTOLOGY; HUMAN; LOGISTIC REGRESSION ANALYSIS; LYMPH NODE METASTASIS; MAMMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; RELIABILITY; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; TUMOR VOLUME;

EID: 0742289088     PISSN: 00099260     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.crad.2003.07.006     Document Type: Article

References (23)

1. Todd JH, Dowle C, Williams MR, et al. Confirmation of a prognostic index in primary breast cancer. Br J Cancer 1987; 56:489-92.
2. Tabar L, Chen HH, Duffy SW, et al. A novel method for prediction of long-term outcome of women wit T1a, T1b, and 10-14 mm invasive breast cancers: a prospective study. Lancet 2000;355:429-33.
3. Thurfjell E, Thurfjell MG, Lindgren A. Mammographic finding as predictor of survival in 1-9 mm invasive breast cancers. Worse prognosis for cases presenting as calcifications alone. Breast Cancer Res Treat 2001;67:177-80.
4. Stata Corporation. STATA 7 user's guide. Texas: College Station; 2001. p. 254-8.
5. James JJ, Evans AJ, Pinder SE. Is the presence of mammographic comedo calcification really a prognostic factor for small screen-detected invasive breast cancers. Clin Radiol 2003;58:54-62.
6. Holland R, Hendriks JHCL, Verbeek ALM, et al. Extent, distribution, and mammographic/histological correlations of breast ductal carcinoma in situ. Lancet 1990;335:519-22.
7. Lagios MD, Margolin FR, Westdahl PR, Rose MR. Mammographically detected duct carcinoma in situ. Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence. Cancer 1989;63: 618-24.
8. McKee GT, Tildsley G, Hammond S. Cytologic diagnosis and grading of ductal carcinoma in situ. Cancer 1999;87:203-9.
9. Stomper PC, Connolly JL. Ductal carcinoma in situ of the breast: correlation between mammographic calcification and tumour subtype. AJR Am J Roentgenol 1992;159:483-5.
10. Hermann G, Keller RJ, Drossman S, et al. Mammographic pattern of microcalcifications in the preoperative diagnosis of comedo ductal carcinoma in situ: histopathologic correlation. Can Assoc Radiol J 1999;50:235-40.
11. Lee KS, Han BH, Chun YK, Kim HS, Kim EE. Correlation between mammographic manifestations and averaged histopathologic nuclear grade using prognosis-predict scoring system for the prognosis of ductal carcinoma in situ. Clin Imaging 1999;23:339-46.
12. Dinkel HP, Gassel AM, Tschammler A. Is the appearance of microcalcifications on mammography useful in predicting histological grade of malignancy in ductal cancer in situ? Br J Radiol 2000;73:938-44.
13. Evans AJ, Pinder SE, Ellis IO, Wilson AR. Screen-detected ductal carcinoma in situ (DCIS): overdiagnosis or an obligate precursor of invasive disease? J Med Screening 2001;8: 149-51.
14. Evans AJ, Pinder SE, Ellis IO, et al. Correlations between the mammographic features of ductal carcinoma in situ (DCIS) and CerbB-2 oncogene expression. Clin Radiol 1994;49: 559-62.
15. Silverstein MJ, Poller DN, Waisman JR, et al. Prognostic classification of breast ductal carcinoma in-situ. Lancet 1995;345:1154-7.
16. Silverstein MJ, Lagios MD. Use of predictors of recurrence to plan therapy for DCIS of the breast. Oncology 1997;11: 393-406.
17. Eusebi V, Feudale E, Foschini MP, et al. Long-term follow-up of in situ carcinoma of the breast. Semin Diagn Pathol 1994; 11:223-35.
18. Crombie N, Rampaul RS, Pinder SE, et al. Extent of ductal carcinoma in situ within and surrounding invasive primary breast carcinoma. Br J Surg 2001;88:1324-9.
19. Bartelink H, Borger JH, van Dongen JA, Peterse JL. The impact of tumor size and histology on local control after breast-conserving therapy. Radiother Oncol 1988;11: 297-303.
20. Osteen RT, Connolly JL, Recht A, et al. Identification of patients at high risk for local recurrence after conservative surgery and radiation therapy for stage I or II breast cancer. Arch Surg 1987;122:1248-52.
21. Bagnall MJC, Evans AJ, Wilson RM, et al. Predicting invasion in mammographically detected microcalcification. Clin Radiol 2001;56:828-32.
22. Lampejo OT, Barnes DM, Smith P, Millis RR. Evaluation of infiltrating ductal carcinomas with a DCIS component: correlation of the histologic type of the in situ component with grade of the infiltrating component. Semin Diag Pathol 1994;11:215-22.
23. Evans AJ, Pinder SE, Snead DRJ, et al. The detection of ductal carcinoma in situ at mammographic screening enables the diagnosis of small, grade 3 invasive tumours. Br J Cancer 1997;75:542-4.